Combating immunotherapy resistance in melanoma: an interview with Jacob Zaemes and Michael Atkins

Written by Michael B Atkins, MD and Jacob Zaemes, MD (both Georgetown University, DC, USA).

immunotherapy resistance in melanoma

Oncology Central recently spoke with Michael B Atkins, MD and Jacob Zaemes, MD (both Georgetown University, DC, USA). Atkins is the Deputy Director of Georgetown Lombardi Comprehensive Cancer Center and William M Scholl Professor and Vice Chair of the Department of Oncology at Georgetown University Medical Center, and a medical oncologist with a longstanding clinical and research interest in melanoma and kidney cancer therapy, immunotherapy, targeted and anti-angiogenic therapy and predictive biomarker research. Zaemes is a resident in the Internal Medicine at MedStar Georgetown University Hospital.  His research interests include immunotherapy and targeted therapy in solid tumors. In this interview,...

To view the full article, please register now for access

It's completely free